Skip to main content

Advertisement

Log in

New technologies aiding dietary programmes for weight control: the oral glucose spray

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

To determine whether the administration of small amounts of glucose through an oral spray device (GSD) facilitates weight loss in overweight/obese subjects involved in a lifestyle modification programme. We randomly assigned 56 overweight/obese subjects to either the treatment group (n = 32) or the control group (n = 24). All subjects in both groups followed a structured dietary programme of 6,280.2 kJ (1,500 kcal)/day and exercised minimum 150 min a week and were followed-up for a period of 60 days. Subjects assigned to the treatment group were asked to spray, during early symptoms of neuroglycopenia, 10 puffs by GSD. GSD is a device that delivers to the buccal mucosa 50 mg of glucose per puff. A mean weight loss of 3.5 ± 3.0 kg in GSD-treated group compared to 1.7 ± 2.1 kg in control group (p = 0.01) was observed. Significant differences regarding reduction of BMI (−1.3 ± 1.0 vs −0.7 ± 0.8 kg/m2; p = 0.01) and waist circumference (−3.5 ± 3.2 vs −0.9 ± 3.5 cm; p = 0.02) were also detected. A short-term use of GSD, in association with dietary restriction and exercise, is helpful in improving weight loss and in reducing waist circumference in overweight/obese subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization (WHO), Nutrition. Controlling the global obesity epidemic (2010), http://www.who.int. Accessed 15 Jan 2011

  2. Trust for America’s Health, F as in fat: how obesity policies are failing in America (2010), http://healthyamericans.org/reports/obesity2007/. Accessed 20 Jan 2011

  3. S. O’Rahilly, Human genetics illuminates the paths to metabolic disease. Nature 19, 307–314 (2009)

    Article  Google Scholar 

  4. C.J. Lavie, R.V. Milani, H.O. Ventura, Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J. Am. Coll. Cardiol. 53, 1925–1932 (2009)

    Article  PubMed  Google Scholar 

  5. J.P. Chaput, A. Tremblay, The glucostatic theory of appetite control and the risk of obesity and diabetes. Int. J. Obes. 33, 46–53 (2009)

    Article  Google Scholar 

  6. B.M. Popkin, P. Gordon-Larsen, The nutrition transition: worldwide obesity dynamics and their determinants. Int. J. Obes. Relat. Metab. Disord. 28, S2–S9 (2004)

    Article  PubMed  Google Scholar 

  7. R.K. Johnson, L.J. Appel, M. Brands, B.V. Howard, M. Lefevre, R.H. Lustig, F. Sacks, L.M. Steffen, J. Wylie-Rosett, American Heart Association nutrition committee of the council on nutrition, physical activity, and metabolism and the council on epidemiology and prevention.: dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation 120, 1011–1020 (2009)

    Article  CAS  PubMed  Google Scholar 

  8. J.O. Hill, Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev 27, 750–761 (2006)

    Article  PubMed  Google Scholar 

  9. W. Kopp, High-insulinogenic nutrition—an etiologic factor for obesity and the metabolic syndrome? Metabolism 52, 840–844 (2003)

    Article  CAS  PubMed  Google Scholar 

  10. S.B. Roberts, Glycemic index and satiety. Nutr. Clin. Care 6, 20–26 (2003)

    PubMed  Google Scholar 

  11. W.D. McArdle, F.L. Katch, V.L. Katch, Essentials of exercise physiology (Lippincott, Williams & Wilkins, Baltimore, 2000)

    Google Scholar 

  12. J.C. Brand-Miller, S.H. Holt, D.B. Pawlak, J. McMillan, Glycemic index and obesity. Am. J. Clin. Nutr. 76, 281S–285S (2002)

    CAS  PubMed  Google Scholar 

  13. L. Velázquez-López, E. González-Figueroa, P. Medina-Bravo, I. Pineda-Del Aquila, L. Avila-Jiménez, R. Ramos-Hernández, M. Klunder–Klunder, J. Escobedo-de la Peña, Low calorie and carbohydrate diet: to improve the cardiovascular risk indicators in overweight or obese adults with prediabetes. Endocrine (2012). doi:10.1007/s12020-012-9775-z

    PubMed  Google Scholar 

  14. P. Cryer, The prevention and correction of hypoglycemia, in Handbook of physiology, ed. by L. Jefferson, A. Cherrington, H. Goodman (Oxford University Press, New York, 2001), pp. 1057–1092

    Google Scholar 

  15. N.M. Sanders, D.P. Figlewicz, G.J. Taborsky Jr, C.W. Wilkinson, W. Daumen, B.E. Levin, Feeding and neuroendocrine responses after recurrent insulin-induced hypoglycaemia. Physiol. Behav. 87, 700–706 (2006)

    Article  CAS  PubMed  Google Scholar 

  16. Y.M. Khazrai, F. Cacciapaglia, A. Picardi, G. Beretta Anguissola, C. Guglielmi, S. Manfrini, P. Pozzilli, Treatment of symptoms of neuroglycopenia with glucose RapidSprayTM to avoid rebound hyperglycaemia. Diabetes 57(suppl 1), A 564 (2008)

    Google Scholar 

  17. K.A. McAuley, K.J. Smith, R.W. Taylor, R.T. McLay, S.M. Williams, J.I. Mann, Long-term effects of popular dietary approaches on weight loss and features of insulin resistance. Int. J. Obes. 30, 342–349 (2006)

    Article  CAS  Google Scholar 

  18. A. Flint, A. Raben, J.E. Blundell, A. Astrup, Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int. J. Obes. Relat. Metab. Disord. 24, 38–48 (2000)

    Article  CAS  PubMed  Google Scholar 

  19. G. Reaven, F. Abbasi, T. McLaughlin, Obesity, insulin resistance, and cardiovascular disease. Recent Prog. Horm. Res. 59, 207–223 (2004)

    Article  CAS  PubMed  Google Scholar 

  20. D.E. Thomas, E.J. Elliott, L. Baur, Low glycaemic index or low glycaemic load diets for overweight and obesity. Cochrane Database Syst. Rev. 3, CD005105 (2007)

    PubMed  Google Scholar 

  21. Y.M. Khazrai, F. Cacciapaglia, A. Palermo, P. Pozzilli, The use of glucose spray device to control progression towards hypoglycaemia. Endocrine 42, 442–444 (2012)

    Article  CAS  PubMed  Google Scholar 

  22. K. Hodgson, B. Govan, N. Ketheesan, J. Morris, Dietary composition of carbohydrate contributes to the development of experimental type 2 diabetes. Endocrine 43, 447–451 (2013)

    Article  CAS  PubMed  Google Scholar 

  23. E.S. Chambers, M.W. Bridge, D.A. Jones, Carbohydrate sensing in the human mouth: effects on exercise performance and brain activity. J. Physiol. 15, 1779–1794 (2009)

    Article  Google Scholar 

  24. J.M. Carter, A.E. Jeukendrup, D.A. Jones, The effect of carbohydrate mouth rinse on 1-h cycle time trial performance. Med. Sci. Sports Exerc. 36, 2107–2111 (2004)

    Article  CAS  PubMed  Google Scholar 

  25. C. Colantuoni, J. Schwenker, J. McCarthy, P. Rada, B. Ladenheim, J.L. Cadet, G.J. Schwartz, T.H. Moran, B.G. Hoebel, Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. NeuroReport 12, 3549–3552 (2001)

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

This study was supported by an educational grant to the University Campus Bio-Medico of Rome by Generex Biotechnology Inc. Generex Biotechnology Inc. gave us Glucose Rapid Spray for the trial. The sponsor had no role in the study design, data collection, data analysis or interpretation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yeganeh Manon Khazrai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khazrai, Y.M., Maddaloni, E., Altomare, M. et al. New technologies aiding dietary programmes for weight control: the oral glucose spray. Endocrine 45, 288–292 (2014). https://doi.org/10.1007/s12020-013-9987-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-013-9987-x

Keywords

Navigation